TD SYNNEX Corporation
NYSE:SNXTechnology Distributors
+$0.39 today
- Market cap
- $18.50B
- Beta
- 1.44
- P/E (TTM)
- 23.0
- EPS (TTM)
- $12.34
- Dividend yield
- 0.65%
Volume 0.48M
Average 0.83M
SNX Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
TD SYNNEX CorporationNYSE: SNX
Gross Margin · Q3 FY2026 · quarter ended Aug 2026
Gross margin holds steady near 6.6%
Gross margin was 6.6% in Q3 FY2026, down 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 6.8%, up 0.5 pp year over year. Over 3 fiscal years it widened by 1.3 pp.
Context
- Gross margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 7.0%
- Year-over-year change
- +0.9pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | 7.0% | +0.9pp |
| FY2024 | 2024-11-30 | 6.1% | -0.2pp |
| FY2023 | 2023-11-30 | 6.2% | +0.5pp |
| FY2022 | 2022-11-30 | 5.7% | +0.1pp |
| FY2021 | 2021-11-30 | 5.6% | — |
Gross Margin vs competitors
How SNX compares with its peers on the latest reported figures
- SNX's LTM Aug 2026 gross margin of 6.8% is the lowest of the 6 companies compared; the peer median is 13.3%.
- Its year-over-year change of +0.5 pp is the highest of 6, against a peer median of -0.1 pp.
- Over three fiscal years its change of +1.3 pp compares with a peer median of +1.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 21.4% | -0.2 pp | +2.0 pp | |
| LTM Sep 2026 | 18.6% | +0.1 pp | +1.9 pp | |
| LTM Mar 2026 | 13.3% | -0.1 pp | +1.4 pp | |
| LTM Jul 2026 | 11.2% | -0.1 pp | -1.8 pp | |
| LTM Oct 2026 | 10.3% | -0.3 pp | -1.6 pp | |
| LTM Aug 2026 | 6.8% | +0.5 pp | +1.3 pp | |
| Peer median (excluding SNX) | 13.3% | -0.1 pp | +1.4 pp | |
Competitors are the stored peer set for SNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Revenue | 31.61B | 62.34B | 57.56B | 58.45B | 62.51B |
| Cost of Revenue | 29.85B | 58.78B | 53.97B | 54.92B | 58.14B |
| Gross Profit | 1.77B | 3.56B | 3.58B | 3.54B | 4.37B |
| Gross Margin | 5.6% | 5.7% | 6.2% | 6.1% | 7.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.05B | 2.33B | 2.25B | 2.31B | 2.95B |
| Operating Expenses | 1.05B | 2.33B | 2.25B | 2.31B | 2.95B |
| Depreciation & Amortization | 151.66M | 463.37M | 418.32M | 407.53M | 414.22M |
| EBITDA | 734M | 1.49B | 1.51B | 1.6B | 1.83B |
| EBITDA Margin | 2.3% | 2.4% | 2.6% | 2.7% | 2.9% |
| Operating Income | 717.3M | 1.23B | 1.33B | 1.23B | 1.42B |
| Operating Margin | 2.3% | 2.0% | 2.3% | 2.1% | 2.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 115.85M | 197.94M | 306.96M | 329.78M | 356.61M |
| Other Income / Expenses | (250.81M) | (407.7M) | (538.1M) | (362.52M) | (364.85M) |
| Income Before Tax | 466.49M | 827.13M | 789.51M | 866.04M | 1.06B |
| Pre-Tax Margin | 1.5% | 1.3% | 1.4% | 1.5% | 1.7% |
| Income Tax Expense | 71.42M | 175.82M | 162.6M | 176.94M | 229.59M |
| Net Income | 395.07M | 651.31M | 626.91M | 689.09M | 827.66M |
| Net Margin | 1.2% | 1.0% | 1.1% | 1.2% | 1.3% |
| EPS (Basic) | 6.28 | 6.79 | 6.72 | 7.99 | 10.08 |
| EPS (Diluted) | 6.24 | 6.77 | 6.70 | 7.95 | 9.95 |
| Weighted Avg Shares | 62.24M | 95.23M | 92.57M | 85.49M | 82.1M |
| Weighted Avg Shares (Diluted) | 62.7M | 95.51M | 92.85M | 85.87M | 82.43M |
TD SYNNEX Corporation
NYSE:SNX
Intrinsic Alpha fair value
Locked
Current Price
$231.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.